O
TPTX
OrbiMed’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,012,250
| Closed | -$151K | – | 150 |
|
|
2022
Q2 | $151K | Sell |
2,012,250
-6,700
| -0.3% | -$504 | 2.74% | 6 |
|
|
2022
Q1 | $54.2M | Sell |
2,018,950
-87,500
| -4% | -$2.35M | 0.88% | 36 |
|
|
2021
Q4 | $100M | Sell |
2,106,450
-254,877
| -11% | -$12.2M | 1.29% | 27 |
|
|
2021
Q3 | $157M | Hold |
2,361,327
| – | – | 1.72% | 15 |
|
|
2021
Q2 | $184M | Hold |
2,361,327
| – | – | 1.86% | 14 |
|
|
2021
Q1 | $223M | Sell |
2,361,327
-384,000
| -14% | -$36.3M | 2.09% | 13 |
|
|
2020
Q4 | $335M | Hold |
2,745,327
| – | – | 2.93% | 6 |
|
|
2020
Q3 | $240M | Hold |
2,745,327
| – | – | 3.01% | 5 |
|
|
2020
Q2 | $177M | Hold |
2,745,327
| – | – | 2.5% | 11 |
|
|
2020
Q1 | $123M | Hold |
2,745,327
| – | – | 2.06% | 14 |
|
|
2019
Q4 | $171M | Hold |
2,745,327
| – | – | 2.44% | 12 |
|
|
2019
Q3 | $103M | Buy |
2,745,327
+177,777
| +7% | +$6.68M | 1.96% | 13 |
|
|
2019
Q2 | $104M | Buy |
+2,567,550
| New | +$104M | 1.62% | 16 |
|